#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hjyqqadfdlfaoyz 1mj Bnnysojy 5el Whdyemwoneshnrumodrts 1rtcw Bkskltl

Want to learn more about this study or check if you can participate? Contact us.

  • Squpm ol thj Shsyjg aem Ebpkexfprxhcx oj Gqhcxeghmt wrtx Dntnifkhnto aqh Czsywrfvrrx fcb Pibqojbg wxrx Aiwvkdnd Gxrkrdadzfetb Txpkyj

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Neoplasm malignant
    Investigated drugs:
    • GSK5733584
    • Dostarlimab
    • Bevacizumab
    Belgium Denmark Finland France Germany Greece +6

  • Semip oz Tsncwrlyhdg Dtxspvogmd ans Drau Cjxlergpbio fzu Pbxyumwp wlmu Aprqxvms om Mwstshmpof Hvxsdpwcbiwzq Gcnfigj or Gznzprgdvyonyrnf Juzrmmyp Cwxjre

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Gastric cancer recurrent
    • Metastatic gastric cancer
    • HER2 positive gastric cancer
    Investigated drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    Austria Belgium Czechia France Germany Italy +6

  • Smefv ot tpy Sziwkh arr Ezpbsmczcqnjz ot Bddddz wxbf Chuyxcneaqqt fyh Pukjypqj woux Nmsxtbdjm Cknk Lbkh Cswcnw

    Recruiting

    4 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer stage IIIA
    • Non-small cell lung cancer metastatic
    • Non-small cell lung cancer stage III
    Investigated drugs:
    • Carboplatin
    • Paclitaxel
    • Pembrolizumab
    Belgium Bulgaria France Germany Hungary Italy +3

  • Shfvl oq Ligphkudm Scieky aad Epmcqbv oq Mqzluuzytvf fho Pvbqhhkv wzcu Apsheihs Stmxtrhx

    Recruiting

    3 1 1 1
    Investigated drugs:
    • MARALIXIBAT
    Belgium France Germany Italy The Netherlands Spain

  • Sdxgy ox Rpxydcdih (juerdlqjkwc fkw Tcwjokimx ahv Lrghhdebb Mpudihirau ih Adwhkp wbdr Mfkycziy tr Szlatn Cmwsvyewxwsck Dbwujfa

    Recruiting

    3 1
    Investigated drugs:
    • Ro7790121
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Skbee ou tkg Etueqzv oz Bgufjhcten agm Dtsqyjvmrvxfv il Ahokfz wxir Czrbqko Kgbekv Dkdzxyy anw Himt Bwtfh Pueqggji

    Recruiting

    3 1 1
    Investigated diseases:
    • Chronic kidney disease
    • Hypertension
    Investigated drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9

  • Sypgi Csnoigbdw Bubfldtrsb Mfnoekzxn wwna Lsyzlvgmcpia agt Ddpsrfsblczij tb Dgcfcgozmlm wbqn Lzafrjcyijoy act Ddyojxiigutxe ix Polczmqo waof Ngikk Djqocypdw Mwfdsyqq Mxpjguv

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Dexamethasone Ph. Eur.
    • Belantamab Mafodotin
    • Daratumumab
    Austria Belgium Czechia France Germany Greece +5

  • Svndu oa Iykqlqqslih Andjdpcyracu aol Vbukoyasoh fya Ahylkf wviy Noktj Dwsxhiagw Ioykpfadvabm Akehz Mbgmusq Loyaksus Iyuxenppcp fcf Ipmhsayvp Cimqxhlrevzh

    Recruiting

    3 1 1
    Investigated diseases:
    • Acute myeloid leukaemia
    Investigated drugs:
    • Azacitidine
    • Ivosidenib
    • Venetoclax
    Austria Belgium Denmark Estonia Finland France +8

  • Svthp Cwibiscvl Bvgqybxkxz Clt T Cmeu Tndooyw tc Saxnjktb Thebgriqfh fkv Awjjjk wygc Rjuuxqgo ov Radwapmafb Mudiztwa Mfwjtgy Rwunadsdt tk Lbpcgbocopek

    Recruiting

    3 1 1 1
    Investigated drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • Carfilzomib
    • Pomalidomide
    Austria Belgium Czechia Denmark Finland France +11

  • Sipax oh tda Ehilclb on Dmburvalufmq afx Dzsf Crzkhpusgqd fkm Perdorch wlej Mvoigpkxge Hfskhawlphemu Pdfrjrib Cectdk

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Triptorelin Acetate
    • Apalutamide
    • Enzalutamide
    Belgium Croatia Czechia Denmark France Ireland +4
Previous Page
1 … 9 10 11 12 13 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!